Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4
×
alzheimer's disease
cancer
deals
startups
abbvie
aduro biotech
amgen
biogen
cancer immunotherapy
clinical trials
diagnostics
What
drug
4
×
bio
roundup
approval
companies
new
price
acquisitions
alzheimer’s
amgen
biggest
biogen’s
biopharmaceutical
build
buy
candidates
ceo
class
company’s
convo
daniel
debut
developed
different
dyne’s
earlier
fail
failures
fda
gene
gets
gilead
head
increases
latest
littered
medicines
microbiome
migraine
moves
Language
unset
Current search:
drug
×
biotech
×
novartis
×
" wisconsin top stories "
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines